Search details
1.
Mechanistic investigations of the liver toxicity of the free fatty acid receptor 1 agonist fasiglifam (TAK875) and its primary metabolites.
J Biochem Mol Toxicol
; 33(8): e22345, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31066974
2.
Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.
Diabetes Obes Metab
; 20(8): 1836-1851, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29938884
3.
Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5.
Chembiochem
; 17(9): 861-5, 2016 05 03.
Article
in English
| MEDLINE | ID: mdl-26812365
4.
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.
Diabetologia
; 58(3): 549-57, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25417214
5.
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.
Endocrinology
; 159(8): 3105-3119, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29992313
6.
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists.
J Med Chem
; 60(10): 4293-4303, 2017 05 25.
Article
in English
| MEDLINE | ID: mdl-28448133
7.
Correction to Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonist.
J Med Chem
; 60(13): 5941, 2017 07 13.
Article
in English
| MEDLINE | ID: mdl-28677386
8.
Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand.
Bioorg Med Chem Lett
; 14(11): 2801-5, 2004 Jun 07.
Article
in English
| MEDLINE | ID: mdl-15125936
9.
Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents.
Bioorg Med Chem Lett
; 14(16): 4191-5, 2004 Aug 16.
Article
in English
| MEDLINE | ID: mdl-15261268
Results
1 -
9
de 9
1
Next >
>>